Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type III secretion protein PcrV is an indispensable structural regulator at the tip complex of the T3SS "injectisome" used by Gram-negative pathogens like Pseudomonas aeruginosa. It orchestrates assembly/functionality of membrane pores needed to deliver toxic effectors into host cells—a process central to pathogenesis—and serves as both a validated drug target and promising vaccine candidate due to its surface exposure/conservation among clinical isolates.
Inhibition of T3SS mediated effector translocation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type III secretion protein PcrV (PcrV).